Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2023 Apr 21;13:1102269. doi: 10.3389/fonc.2023.1102269

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2023 Bhattacharya and Sharma

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

PMC Copyright notice

(A) represents overexpression of Ki-67 in DMBA treated group. (B) indicating DMBA+DTIC-SLNs-8 decreases proliferative cells in the tumor section in DMBA-induced skin tumors. (C) representing the moderate downregulation of Ki-67 expression. Representative images micrographs of Ki-67 staining (nuclei stained with brown color) in the tumor section of experimental groups are shown. Bar graph is shown the percentage of proliferative cells by counting Ki-67 positive cells in 15 randomly selected microscopic (40× objective) fields in each group were calculated by the total number of cells divided by the number of Ki-67 positive cells. vehicle Control treated group; DMBA treated group; DMBA+ DTIC-SLNs-8 with Gellan gum (0.01%w/v); DMBA+DTIC with Gellan gum (0.01%w/v) Statistical analyses were performed with Student’s t-test *p < 0.01 compared with DMBA alone treated group.